Deep Genomics Funding: $180M Raised, Series C (2021)

Deep Genomics is based in Toronto, Canada. It has raised $180M in total funding. Latest round: Series C.

Deep Genomics funding overview

Deep Genomics is based in Toronto, Canada. Deep Genomics has raised $180M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in July 2021. The round record for Deep Genomics runs through 2021; nothing later has been disclosed. Investors on record include SoftBank Vision Fund 2, CPP Investments, Fidelity Management & Research Company LLC, Alexandria Venture Investments, Amplitude Ventures, Khosla Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.

Deep Genomics at a glance

Total raised
$180M
Latest round
Series C
Latest round date
July 2021
Headquarters
Toronto, Canada
Notable investors
SoftBank Vision Fund 2, CPP Investments, Fidelity Management & Research Company LLC, Alexandria Venture Investments, Amplitude Ventures, Khosla Ventures, Magnetic Ventures, True Ventures

Frequently asked about Deep Genomics funding

How much has Deep Genomics raised?
Deep Genomics has raised $180M in total disclosed funding across the rounds on record.
Who has invested in Deep Genomics?
SoftBank Vision Fund 2, CPP Investments, Fidelity Management & Research Company LLC, Alexandria Venture Investments, Amplitude Ventures, Khosla Ventures are named among the investors backing Deep Genomics.
What was the latest Deep Genomics funding round?
The most recent disclosed round is a Series C, announced in July 2021.
Where is Deep Genomics based?
Deep Genomics is based in Toronto, Canada.
When did Deep Genomics last raise?
The last disclosed Deep Genomics round closed in July 2021 at Series C.

Deep Genomics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Toronto below to benchmark round size and investor mix.

Deep Genomics pitch deck

The investor deck Deep Genomics used to raise — 2021, Series C, 16-slide deck is broken down slide by slide, including the slides it leads with and the questions it leaves open.

Companies related to Deep Genomics (36)

Browse related funding lists (10)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades